Built by operators.
Run by operators.
Founded by biotech executives, our fractional executives are life sciences veterans: proven, vetted, cost-conscious, and highly experienced leaders who speak your language, get your culture, and integrate directly with your team on a part-time or project basis to get you to the next inflection point and beyond.
Alexander Nguyen
Co-Founder (G&A)
Strategic biotech operator and General Counsel with a builder's mindset and a record of launching and scaling early-stage companies at speed. Served as Chief Legal Officer and Head of Operations at UNITY Biotechnology and as a senior executive across multiple Roivant subsidiaries — helping spin out and scale multiple biotech companies from formation through late stage. Deep experience in financings, licensing, governance, and cross-functional execution across legal, compliance, IP, clinical operations, HR, and alliance management. Known for creating the legal and operational backbone early-stage companies need to move fast, efficiently, and avoid costly missteps. A hands-on, trusted partner to founders and boards at every strategic, operational, and organizational inflection point. At MRA, Alex draws on that operating experience to identify and place the G&A and operational talent clients need to execute.
Alexander Nguyen
Co-Founder (G&A)
Strategic biotech operator and General Counsel with a builder's mindset and a record of launching and scaling early-stage companies at speed. Served as Chief Legal Officer and Head of Operations at UNITY Biotechnology and as a senior executive across multiple Roivant subsidiaries — helping spin out and scale multiple biotech companies from formation through late stage. Deep experience in financings, licensing, governance, and cross-functional execution across legal, compliance, IP, clinical operations, HR, and alliance management. Known for creating the legal and operational backbone early-stage companies need to move fast, efficiently, and avoid costly missteps. A hands-on, trusted partner to founders and boards at every strategic, operational, and organizational inflection point. At MRA, Alex draws on that operating experience to identify and place the G&A and operational talent clients need to execute.
Alexander Nguyen
Co-Founder (G&A)
Strategic biotech operator and General Counsel with a builder's mindset and a record of launching and scaling early-stage companies at speed. Served as Chief Legal Officer and Head of Operations at UNITY Biotechnology and as a senior executive across multiple Roivant subsidiaries — helping spin out and scale multiple biotech companies from formation through late stage. Deep experience in financings, licensing, governance, and cross-functional execution across legal, compliance, IP, clinical operations, HR, and alliance management. Known for creating the legal and operational backbone early-stage companies need to move fast, efficiently, and avoid costly missteps. A hands-on, trusted partner to founders and boards at every strategic, operational, and organizational inflection point. At MRA, Alex draws on that operating experience to identify and place the G&A and operational talent clients need to execute.
Anirvan Ghosh, PhD
Co-Founder (R&D)
Accomplished biotech CEO and R&D leader with major contributions across global pharma, public biotech, and academia. As SVP of Research and Early Development at Biogen, directed 350+ scientists with a $400M budget, advancing 10 assets into the clinic. At Roche, as Global Head of Neuroscience Discovery, advanced Risdiplam (FDA-approved, SMA) and the Brain Shuttle platform now in Phase 2/3 trials. As CEO of UNITY Biotechnology, repositioned the company, delivered Phase 2 proof-of-concept in DME, and raised capital through public offerings and strategic partnerships. Deep expertise in drug development, organizational leadership, and corporate strategy across neurology, ophthalmology, and rare disease. Brings the scientific credibility and R&D depth to identify and deploy the right talent at every stage. At MRA, Anirvan draws on that scientific and operational depth to identify and deploy the R&D talent clients need to advance their pipelines.
Anirvan Ghosh, PhD
Co-Founder (R&D)
Accomplished biotech CEO and R&D leader with major contributions across global pharma, public biotech, and academia. As SVP of Research and Early Development at Biogen, directed 350+ scientists with a $400M budget, advancing 10 assets into the clinic. At Roche, as Global Head of Neuroscience Discovery, advanced Risdiplam (FDA-approved, SMA) and the Brain Shuttle platform now in Phase 2/3 trials. As CEO of UNITY Biotechnology, repositioned the company, delivered Phase 2 proof-of-concept in DME, and raised capital through public offerings and strategic partnerships. Deep expertise in drug development, organizational leadership, and corporate strategy across neurology, ophthalmology, and rare disease. Brings the scientific credibility and R&D depth to identify and deploy the right talent at every stage. At MRA, Anirvan draws on that scientific and operational depth to identify and deploy the R&D talent clients need to advance their pipelines.
Anirvan Ghosh, PhD
Co-Founder (R&D)
Accomplished biotech CEO and R&D leader with major contributions across global pharma, public biotech, and academia. As SVP of Research and Early Development at Biogen, directed 350+ scientists with a $400M budget, advancing 10 assets into the clinic. At Roche, as Global Head of Neuroscience Discovery, advanced Risdiplam (FDA-approved, SMA) and the Brain Shuttle platform now in Phase 2/3 trials. As CEO of UNITY Biotechnology, repositioned the company, delivered Phase 2 proof-of-concept in DME, and raised capital through public offerings and strategic partnerships. Deep expertise in drug development, organizational leadership, and corporate strategy across neurology, ophthalmology, and rare disease. Brings the scientific credibility and R&D depth to identify and deploy the right talent at every stage. At MRA, Anirvan draws on that scientific and operational depth to identify and deploy the R&D talent clients need to advance their pipelines.
Our Executives Come From
Our Executives Come From
Our Executives Come From
Built by biotech operators. For biotech operators.
Mission Rock is your Partner
Founded by biotech executives, our fractional executives are life sciences veterans: proven, vetted, cost-conscious, and highly experienced leaders who speak your language, get your culture, and integrate directly with your team on a part-time or project basis to get you to the next inflection point and beyond.
Built by biotech operators. For biotech operators.
Mission Rock is your Partner
Founded by biotech executives, our fractional executives are life sciences veterans: proven, vetted, cost-conscious, and highly experienced leaders who speak your language, get your culture, and integrate directly with your team on a part-time or project basis to get you to the next inflection point and beyond.
Built by biotech operators. For biotech operators.
Mission Rock is your Partner
Founded by biotech executives, our fractional executives are life sciences veterans: proven, vetted, cost-conscious, and highly experienced leaders who speak your language, get your culture, and integrate directly with your team on a part-time or project basis to get you to the next inflection point and beyond.